MarketPulse

ALTITUDE-AD

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Acumen Pharma to Present Alzheimer's Drug Data at BofA Conference

Acumen Pharma to present at BofA Securities conference May 14 ahead of late-2026 Alzheimer's drug trial results.
ABOSmonoclonal antibodyclinical-stage biopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Acumen Pharma to Unveil 2025 Results as Alzheimer's Drug Advances

Acumen Pharmaceuticals will report full-year 2025 financial results on March 26, 2026, as its lead Alzheimer's candidate progresses through Phase 2 trials.
HALOABOSPhase 2 clinical trialfinancial results